MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/pace.14720

Медицинская библиотека · Pacing and clinical electrophysiology : PACE · 2023

Survival, ventricular arrhythmia, and implantable cardioverter-defibrillator usefulness in toxic cardiomyopathy due to substance abuse.

Dognin Nicolas, Rimac Goran, Domain Guillaume, Cinq-Mars Alexandre, Massot Montse, Turgeon Pierre Yves, Dubois-Sénéchal Sacha-Michelle, Bourgault Christine, Morin Joëlle, Bernier Mathieu, Beaudoin Jonathan, Laflamme Maxime, Charbonneau Eric, Strubé Camille, Voisine Pierre, Philippon François, Belzile David, Sénéchal Mario

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Toxic dilated cardiomyopathy (T-DCM) due to substance abuse is now recognized as a potential cause of severe left ventricular dysfunction. The burden of ventricular arrhythmias (VA) and the role of a prophylactic implantable cardioverter-defibrillator (ICD) are not well documented in this population. We aim to assess the usefulness of ICD implantation in a T-DCM cohort.

METHODS

Patients younger than 65 years with a left ventricular ejection fraction (LVEF) < 35% followed at a tertiary center heart failure (HF) clinic between January 2003 and August 2019 were screened for inclusion. The diagnosis of T-DCM was confirmed after excluding other etiologies, and substance abuse was established according to the DSM-5 criteria. The composite primary endpoints were arrhythmic syncope, sudden cardiac death (SCD), or death of unknown cause. The secondary endpoints were the occurrence of sustained VA and/or appropriate therapies in ICD carriers.

RESULTS

Thirty-eight patients were identified, and an ICD was implanted in 19 (50%) of these patients, only one for secondary prevention. The primary outcome was similar between the two groups (ICD vs. non-ICD; p = 1.00). After a mean follow-up of 33 ± 36 months, only two VA episodes were reported in the ICD group. Three patients received inappropriate ICD therapies. One ICD implantation was complicated with cardiac tamponade. Twenty-three patients (61%) had an LVEF ≥35% at 12 months.

CONCLUSION

VA are infrequent in the T-DCM population. The prophylactic ICD benefit was not observed in our cohort. The ideal timing for potential prophylactic ICD implantation in this population needs further studies.

Для цитирования: Dognin Nicolas, Rimac Goran, Domain Guillaume, Cinq-Mars Alexandre, Massot Montse, Turgeon Pierre Yves, Dubois-Sénéchal Sacha-Michelle, Bourgault Christine, Morin Joëlle, Bernier Mathieu, Beaudoin Jonathan, Laflamme Maxime, Charbonneau Eric, Strubé Camille, Voisine Pierre, Philippon François, Belzile David, Sénéchal Mario. Survival, ventricular arrhythmia, and implantable cardioverter-defibrillator usefulness in toxic cardiomyopathy due to substance abuse.. Pacing and clinical electrophysiology : PACE. 2023. DOI: 10.1111/pace.14720.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.